KRAS G12D inhibitors

A compound of formula (I):

• or a pharmaceutically acceptable salt thereof;
• wherein:
• R1 is aryl or heteroaryl, wherein the aryl and the heteroaryl are optionally substituted with one, two, three, four, or five substituents independently selected from C1-C3alkyl, C2-C4alkenyl, C2-C4alkynyl, amino, aminoC1-C3alkyl, C3-C4cycloalkyl, halo, haloC1-C3alkyl, hydroxy, and hydroxyC1-C3alkyl;
• R2 and R3 are independently selected from hydrogen, C1-C3alkoxy, C1-C3alkyl, cyano, halo, haloC1-C3alkyl, and hydroxy;
• R4 is selected from:
• wherein
• Ra is hydrogen or C1-C3alkyl;
• and
• denotes the point of attachment to the parent molecular moiety;
• R5 is selected from
• wherein q, r, and d are each independently 0 or 1;
• and wherein Rx, Ry, and Rp are independently selected from C1-C3alkoxy, C1-C3alkyl, halo, haloC1-C3alkyl, and hydroxy.